EPS for Cantel Medical Corp. (CMD) Expected At $0.60; Tristate Capital Holdings (TSC) Shorts Increased By 2.3%

May 23, 2018 - By Peter Kolinski

Tristate Capital Holdings Inc (NASDAQ:TSC) had an increase of 2.3% in short interest. TSC’s SI was 1.15M shares in May as released by FINRA. Its up 2.3% from 1.12 million shares previously. With 121,300 avg volume, 10 days are for Tristate Capital Holdings Inc (NASDAQ:TSC)’s short sellers to cover TSC’s short positions. The SI to Tristate Capital Holdings Inc’s float is 5.76%. The stock increased 0.37% or $0.1 during the last trading session, reaching $27. About 58,935 shares traded. Tristate Capital Holdings, Inc. (NASDAQ:TSC) has 0.00% since May 23, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.60 EPS on May, 31 before the open.They anticipate $0.09 EPS change or 17.65% from last quarter’s $0.51 EPS. CMD’s profit would be $25.03 million giving it 52.57 P/E if the $0.60 EPS is correct. After having $0.59 EPS previously, Cantel Medical Corp.’s analysts see 1.69% EPS growth. The stock decreased 2.07% or $2.67 during the last trading session, reaching $126.17. About 193,235 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 41.41% since May 23, 2017 and is uptrending. It has outperformed by 29.86% the S&P500.

Among 6 analysts covering TriState Capital Holdings (NASDAQ:TSC), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. TriState Capital Holdings had 26 analyst reports since December 15, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods with “Buy” on Monday, February 26. On Thursday, April 19 the stock rating was maintained by Robert W. Baird with “Hold”. Keefe Bruyette & Woods maintained Tristate Capital Holdings, Inc. (NASDAQ:TSC) rating on Monday, August 21. Keefe Bruyette & Woods has “Buy” rating and $28.0 target. Stephens maintained Tristate Capital Holdings, Inc. (NASDAQ:TSC) on Friday, January 26 with “Buy” rating. The stock of Tristate Capital Holdings, Inc. (NASDAQ:TSC) has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The rating was maintained by Keefe Bruyette & Woods on Friday, March 16 with “Buy”. The company was maintained on Tuesday, December 6 by Maxim Group. Keefe Bruyette & Woods maintained Tristate Capital Holdings, Inc. (NASDAQ:TSC) on Thursday, April 19 with “Buy” rating. The rating was maintained by Maxim Group on Monday, December 19 with “Buy”. The firm has “Buy” rating given on Thursday, January 25 by Maxim Group.

Since January 29, 2018, it had 8 insider buys, and 4 sales for $1.83 million activity. GETZ JAMES F sold $231,780 worth of stock. Shares for $24,048 were bought by Fetterolf Brian S on Friday, February 23. Bonvenuto David L bought $25,000 worth of Tristate Capital Holdings, Inc. (NASDAQ:TSC) on Thursday, March 15. Demas David J bought $50,000 worth of stock. Dolan James J. sold $1.62M worth of stock. $159,000 worth of stock was sold by YASINSKY JOHN B on Friday, May 18.

Investors sentiment decreased to 1.13 in Q4 2017. Its down 0.03, from 1.16 in 2017Q3. It dived, as 8 investors sold Tristate Capital Holdings, Inc. shares while 32 reduced holdings. 8 funds opened positions while 37 raised stakes. 16.85 million shares or 0.74% less from 16.98 million shares in 2017Q3 were reported. Clearbridge has invested 0.25% in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Credit Suisse Ag invested in 14,244 shares or 0% of the stock. Perritt Cap Mgmt stated it has 0.42% of its portfolio in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Bancorp Of America De holds 0% or 14,919 shares. Kestrel Invest holds 1.65% or 205,950 shares. Parametric Ltd Llc stated it has 0% of its portfolio in Tristate Capital Holdings, Inc. (NASDAQ:TSC). Fairview Inv Ltd Liability Co holds 10,000 shares. Qs Invsts Llc holds 0% or 280 shares. Bnp Paribas Arbitrage Sa has 0% invested in Tristate Capital Holdings, Inc. (NASDAQ:TSC) for 9,633 shares. Menta Cap Ltd Liability invested in 69,614 shares or 0.31% of the stock. Wedge Cap Management L L P Nc reported 40,500 shares stake. Janney Montgomery Scott Limited Liability reported 0% stake. Los Angeles Management And Equity Rech reported 27,261 shares. Aqr Cap Mngmt Lc stated it has 52,958 shares. Pnc Finance Ser Grp Inc owns 29,500 shares for 0% of their portfolio.

More notable recent Tristate Capital Holdings, Inc. (NASDAQ:TSC) news were published by: Streetinsider.com which released: “Tristate Capital (TSC) Announces 2.2M Share Common Offering” on May 22, 2018, also Businesswire.com with their article: “TriState Capital Declares Quarterly Dividend on Perpetual Preferred Stock” published on April 30, 2018, Globenewswire.com published: “Investor Expectations to Drive Momentum within Real Goods Solar, Graco, Hibbett Sports, NETGEAR, WD-40, and …” on April 30, 2018. More interesting news about Tristate Capital Holdings, Inc. (NASDAQ:TSC) were released by: Businesswire.com and their article: “TriState Capital Closes Acquisition of Columbia Partners Assets” published on May 04, 2018 as well as Bizjournals.com‘s news article titled: “Here’s why loans rose in 1Q at Pittsburgh banks” with publication date: May 02, 2018.

TriState Capital Holdings, Inc. operates as the bank holding firm for TriState Capital Bank that provides various commercial and private banking services to middle-market businesses and high-net-worth individuals in the United States. The company has market cap of $782.55 million. The firm operates in two divisions, Bank and Investment Management. It has a 20.45 P/E ratio. The Company’s deposit products include checking accounts, money market deposit accounts, and certificates of deposit, as well as promontoryÂ’s certificate of deposit account registry service and insured cash sweep services.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $5.26 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 58.52 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

More news for Cantel Medical Corp. (NYSE:CMD) were recently published by: Bizjournals.com, which released: “Cantel Medical leases Sleep Number’s former headquarters” on May 17, 2018. Benzinga.com‘s article titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” and published on May 15, 2018 is yet another important article.

Among 2 analysts covering Cantel Medical (NYSE:CMD), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Cantel Medical had 2 analyst reports since March 17, 2017 according to SRatingsIntel. Benchmark downgraded Cantel Medical Corp. (NYSE:CMD) on Friday, June 9 to “Hold” rating. The stock has “Mkt Perform” rating by Raymond James on Friday, March 17.

Tristate Capital Holdings, Inc. (NASDAQ:TSC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>